Literature DB >> 1658025

High-performance liquid chromatographic determination of ganciclovir in plasma.

R Boulieu1, N Bleyzac, S Ferry.   

Abstract

A rapid, selective and sensitive isocratic reversed-phase high-performance liquid chromatographic method for the determination of ganciclovir in plasma samples was developed. This method, which was applied to the analysis of plasma ganciclovir from heart transplant patients under ganciclovir therapy for cytomegalovirus infections, represents a suitable analytical tool for drug monitoring and pharmacokinetic investigations.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1658025

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

1.  Acyclovir, ganciclovir, and zidovudine transfer into rat milk.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing Regimens.

Authors:  Thomas Tängdén; Pier Giorgio Cojutti; Jason A Roberts; Federico Pea
Journal:  Clin Pharmacokinet       Date:  2018-11       Impact factor: 6.447

3.  Clinical use of ganciclovir during renal failure and continuous hemodialysis.

Authors:  O Bastien; R Boulieu; N Bleyzac; S Estanove
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

4.  Pharmacokinetics of ganciclovir in a patient undergoing chronic haemodialysis.

Authors:  F Combarnous; D Fouque; N Bernard; R Boulieu; P Chossegros; M Laville; P Zech
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.